| Name | Title | Contact Details |
|---|
ABOUT KSB KSB is one of the worlds leading suppliers of pumps, valves and related systems. KSB combines innovative technology and excellent service to provide intelligent solutions. This approach means that KSB employees are close to customers on all continents, providing them with pumps, valves and systems for almost all applications involving the transportation of liquids. A comprehensive range of services rounds off this customer-focused portfolio. KSB has been growing continuously since it was founded in 1871. Today the Group has a presence on all continents with its own sales and marketing companies, manufacturing facilities and service operations. More than 15,600 employees generate annual consolidated sales revenue of two billion euros. KSB WORLDWIDE With production plants, sales offices and agents in more than 100 countries, KSB is close to its customers throughout the world. Direct contact with local KSB specialists makes it easier for companies to implement their projects quickly, flexibly and at a high level of quality. KSB IN THE MEDIA www.facebook.com/KSB.Company www.twitter.com/KSBcompany www.youtube.com/user/ksbcompany https://www.instagram.com/ksbcompany/ FROM A SINGLE SOURCE: PUMPS AND VALVES, SERVICES AND SYSTEMS: • Pumps and valves for industrial applications • Comprehensive KSB services and original spare parts • Pumps, valves and systems for building services • Automation and drive solutions • Pumps, valves and systems for renewable energy applications • Slurry pumps for mining, suction dredgers and the oil sand industry • Pumps, valves and systems for water applications • Pumps, valves and systems for waste water applications • Pumps, valves and systems for energy applications
Citizens Bank & Trust Company of Campbellsville, KY is a banking company based out of 201 E MAIN ST, Campbellsville, Kentucky, United States.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Authentic® is a community of Fractional CMOs who help growing businesses Overcome Random Acts of Marketing® and confidently take the next right step to build revenue. Our unique approach combines Marketers + Methodology + Mindshare to build strong, strategic, sales-aligned marketing teams and programs.